Pfizer is a leading gene therapy developer, yet is facing setbacks in its studies. Unexpected findings in the study has lead Pfizer to...

The Hemophilia Foundation of Southern California is hosting a Unite for Bleeding Disorder Hemophilia event to raise funds for supporting...

Uniqure's experimental gene therapy called etranacogene dezaparvovec (AMT-061), has entered Phase III of its studies and testing. The...